Martin D W, Sachs J R
Division of Hematology, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794-8151, USA.
Biochemistry. 1999 Jun 8;38(23):7485-97. doi: 10.1021/bi983019b.
The phosphorylation capacity of Na+,K+-ATPase preparations in common use is much less than expected on the basis of the molecular weight of the enzyme deduced from cDNA sequences. This has led to the popularity of half-of-the-sites or flip-flop models for the enzyme reaction mechanism. We have prepared Na+,K+-ATPase from nasal salt glands of salt-adapted ducks which has a phosphorylation capacity and specific activity near the theoretical maxima. Preparations with specific activities of >60 micromol (mg of protein)-1 min-1 at 37 degrees C had phosphorylation capacities of >60 nmol/mg of protein, and the rate of turnover of the enzyme was 9690 min-1, within the range reported for the enzyme from other sources. The fraction of the maximal specific activity of the enzyme compared well with the fraction of the protein on SDS-PAGE which was alpha and beta chains, especially at the highest specific activity which indicates that all of the alphabeta protomers are active. The gels of the most reactive preparations contained only alpha and beta chains, but less active preparations contained a number of extraneous proteins. The major contaminant was actin. The preparation did not contain any protein which migrated in the molecular weight range of the gamma subunit. The subunit composition of the enzyme was alpha1 and beta1 only. This is the first report of a pure, homogeneous, fully active preparation of the protein. Reaction models which incorporate a half-of-the-sites or flip-flop mechanism do not apply to this enzyme.
常用的钠钾ATP酶制剂的磷酸化能力远低于根据从cDNA序列推导的酶分子量所预期的水平。这使得半位点或交替模型在酶反应机制中广受欢迎。我们从适应盐分的鸭的鼻盐腺中制备了钠钾ATP酶,其磷酸化能力和比活性接近理论最大值。在37℃下比活性>60微摩尔/(毫克蛋白质)·分钟的制剂,其磷酸化能力>60纳摩尔/毫克蛋白质,酶的周转速率为9690分钟-1,在其他来源报道的该酶的范围内。该酶最大比活性的比例与SDS-PAGE上α链和β链蛋白质的比例相当,特别是在最高比活性时,这表明所有的αβ原聚体都是有活性的。活性最高的制剂的凝胶只含有α链和β链,但活性较低的制剂含有一些无关蛋白质。主要污染物是肌动蛋白。该制剂不含有任何在γ亚基分子量范围内迁移的蛋白质。该酶的亚基组成仅为α1和β1。这是关于该蛋白质纯的、均质的、完全活性制剂的首次报道。包含半位点或交替机制的反应模型不适用于这种酶。